
Bayer seeks Japenese nod for Aflibercept to treat macular edema following retinal vein occlusion
Berlin: Bayer has submitted an application to the Japanese Ministry of Health, Labour and Welfare (MHLW) seeking approval of aflibercept 8 mg (114.3 mg/ml solution for injection) for the treatment of patients with macular edema following retinal vein …